The CDMO is building identical large-scale production facilities in the U.S. and Europe, designed to modularly and seamlessly integrate manufacturing regardless of location.
Backed by Delin Ventures, the company aims to transform cancer treatment by creating therapies achieving long-term remission for patients with advanced metastatic cancers.
On average, survey participants said they expect a decline in services spending this year versus 2024, according to a survey commissioned by analyst firm Leerink Partners.
